top of page
시험관

Life-Changing Innovations

Through Exosome Platform Technologies. 

Team
CORPORATE DIRECTION
OUR VISION
To create the most compelling exosomes biotech company in the world through development of aesthetics and therapeutics portfolio.
OUR MISSION
To bring unprecedented innovations in aesthetics and therapeutics and make them universally accessible and valuable.
Limitless Possibilities by ZISHEL BIO
ONE-STOP HARVESTING TO PURIFICATION
Driven by In-House Harvesting Laboratory Clinic within Medical Devices Grade Facility.
1M+ 
Monthly Capacity in Vials. Available Yearly Capacity of 12M  vials.
Experienced & Agile
Robust Management Team comprised of medical doctors, engineers, and former CEO and directors of stocks exchange listed companies. 
32+
Global Partnerships in +32 Countries. Creating Exclusive Network of Trustworthy Partners.
Medical Devices Injectable Grade GMP Facility
Rigorous standards approved exosomes production in accordance with injectable grade ISO 13485 GMP.
OUR LEADERSHIP
EXECUTIVE MANAGEMENT 
JONG WOO KIM
CEO

CEO/President of ZISHEL GROUP +8 Years

Research at Biomimetic Laboratory of Harvard Medical School

Research at Nano-Bio Modeling Lab of Georgia Institute of Technology

JUN SEOK CHOI
CBO

CMO of RF BIO

Head of Sales & Marketing of Hugel Inc.+12 Years

Business Leader of Hanall Biopharma (KOSPI. 009420)

MYUNG SUK KIM
COO

COO of Pharmicell (KOSPI. 005690)

GM of ISU Chemicals (KOSPI. 0005950) 

Vice President of Theraject Asia

Strategic Consultant of Daewoo Group

JUNG HYUN YUN
CHIEF ALLIANCE DIRECTOR

CEO of BIOSOLUTION(KOSDAQ. A086820) +12 Years

Vice CEO of Vantage Consulting Firm (M&A division)

EXECUTIVE BOARD OF DIRECTORS
MIN BAE KIM  M.D.
CHAIRMAN OF THE BOARD / CHIEF MEDICAL OFFICER

+30 YEARS as ENT and Plastic Surgeon

Keynote speaker for AMWC, ECS, ICAD, and MCAS.

Key trainer at TESS, ZISHEL, Hugel, and Daewoong.

Founder of Anti-Aging Research T-Lab at Yale University

GIL BONG HWANG
CHAIRMAN

CEO/President of Hugel Pharma (Hugel Inc. Present KOSDAQ .145020)

Vice President of Avellino Laboratory

Director of GSK

%5BZISHEL%5D%20Dubai%20Derma%201_edited.jpg
CORPORATE HISTORY
Creating Valuable Experiences through our Developent 

2020.08

Foundation

 

ZISHEL BIO FoundedAcquired Stem Cell Research Team with +20 years

 

Developed Stem Cell Skincare and Programs with ChaMeditec

2022.06

One Stop Production to Commercialization

R&D and Factory Plant (Annual capacity 12M vials) Opened

ZISHEL Clinic Opening and Integration of Harvesting Lab

2022.06

Global Entry and Branding

Launched XOMAGE and ZEXOGEN at international congresses including AMWC, Dubai Derma, and IMCAS.

Published journal on the proprietary PURIMAX Technology

Signed global distribution partnerships for 32+ countries

~Present

Scale Up and Standardization

Factory Certified under Medical Devices Implants and Cosmetics GMP.

Signed R&D collaborations with KonKuk University  Stem Cell Research Laboratory 

Established Research Instittute

bottom of page